Literature DB >> 7811401

Mechanisms of unpredictable adverse drug reactions.

M J Rieder1.   

Abstract

Adverse drug reactions are common problems associated with therapy, and are major sources of morbidity and mortality. There are numerous types of drug reactions, including predictable drug reactions such as side effects, toxicity, drug interactions and secondary effects that can be anticipated when planning therapy. There are also a number of unpredicted adverse effects, which are unexpected consequences of therapy. The least severe unpredicted adverse drug reaction is intolerance, which appears to be an exaggeration of pharmacological or toxic effects of the drug among vulnerable subsets of patients. Some of the most severe and life-threatening adverse drug reactions are allergic. These adverse effects can be mediated by a number of mechanisms, including the development of drug-specific IgE, serum-sickness-like reactions in response to drug-antibody complexes, direct release of inflammatory mediators, or involvement of the immune system by mechanisms that are poorly understood. Idiosyncratic adverse drug reactions are a heterogeneous group of adverse effects that are not predictable from the pharmacological actions of the drug. Many of these reactions occur as a consequence of pharmacogenetic variations in drug bioactivation and drug or metabolite detoxification or clearance. The physician must be vigilant for the possibility of unpredictable adverse drug reactions during or after therapy. Research currently underway may afford the opportunity to predict, and hopefully prevent, some of these adverse reactions in the future.

Entities:  

Mesh:

Year:  1994        PMID: 7811401     DOI: 10.2165/00002018-199411030-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  97 in total

1.  Side-chain specific beta-lactam allergy.

Authors:  N F Adkinson
Journal:  Clin Exp Allergy       Date:  1990-09       Impact factor: 5.018

2.  Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine.

Authors:  M W Anderson; R D deShazo
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

3.  Sulfamethoxazole is metabolized to the hydroxylamine in humans.

Authors:  A E Cribb; S P Spielberg
Journal:  Clin Pharmacol Ther       Date:  1992-05       Impact factor: 6.875

4.  Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1975

5.  Valproic acid hepatic fatalities: a retrospective review.

Authors:  F E Dreifuss; N Santilli; D H Langer; K P Sweeney; K A Moline; K B Menander
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

6.  A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.

Authors:  E Steiner; L Iselius; G Alván; J Lindsten; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1985-10       Impact factor: 6.875

7.  Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.

Authors:  P J Neuvonen; R A Tokola; M Kaste
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.

Authors:  J S Leeder; A Nakhooda; S P Spielberg; H M Dosch
Journal:  Biochem Pharmacol       Date:  1991-02-15       Impact factor: 5.858

9.  Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.

Authors:  D M Grant; M Blum; M Beer; U A Meyer
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

10.  In vitro evaluation of a toxic metabolite of sulfadiazine.

Authors:  N H Shear; S P Spielberg
Journal:  Can J Physiol Pharmacol       Date:  1985-11       Impact factor: 2.273

View more
  8 in total

1.  Recognizing idiosyncratic adverse drug reactions in children: A practice imperative.

Authors:  B Carleton; D Primmett
Journal:  Paediatr Child Health       Date:  2001-04       Impact factor: 2.253

2.  Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.

Authors:  I Tegeder; M Levy; U Muth-Selbach; R Oelkers; F Neumann; H Dormann; T Azaz-Livshits; M Criegee-Rieck; H T Schneider; E Hahn; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

Review 3.  Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; B K Park
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

4.  Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.

Authors:  H Dormann; U Muth-Selbach; S Krebs; M Criegee-Rieck; I Tegeder; H T Schneider; E G Hahn; M Levy; K Brune; G Geisslinger
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

5.  Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.

Authors:  Tobias Egger; Harald Dormann; Gabi Ahne; Ulrich Runge; Antje Neubert; Manfred Criegee-Rieck; Karl G Gassmann; Kay Brune
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Preventing the Return of Fear Using Reconsolidation Update Mechanisms Depends on the Met-Allele of the Brain Derived Neurotrophic Factor Val66Met Polymorphism.

Authors:  Manish Kumar Asthana; Bettina Brunhuber; Andreas Mühlberger; Andreas Reif; Simone Schneider; Martin J Herrmann
Journal:  Int J Neuropsychopharmacol       Date:  2015-12-30       Impact factor: 5.176

7.  Oseltamivir (Tamiflu)-induced Bilateral Ciliochoroidal Effusion and Angle Closure Glaucoma: What Type of Idiosyncratic Reaction?

Authors:  Shahin Yazdani; Hamed Esfandiari; Sare Safi; Alireza Fatemi
Journal:  J Ophthalmic Vis Res       Date:  2017 Oct-Dec

8.  SuperPred 3.0: drug classification and target prediction-a machine learning approach.

Authors:  Kathleen Gallo; Andrean Goede; Robert Preissner; Bjoern-Oliver Gohlke
Journal:  Nucleic Acids Res       Date:  2022-05-07       Impact factor: 19.160

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.